open science


Academia.edu and the Evolution of Peer Review with Richard Price

Podcast brought to you by: Assay Depot - the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.

Guest:

Richard Price, Academia.edu Bio and Contact Info

Chapters (Move marker to advance)

0:50 Connections between entrepreneurship and philosophy

6:19 How did you get a ".edu" address?

10:04 Difference from other platforms (Mendeley, Google Scholar)

14:37 Peer review is evolving

24:17 What are the privacy challenges for the new model?

26:42 Site numbers

28:42 Can research truly be sped up?

33:34 What's your ultimate goal for the site?

38:46 How do you monetize scientific content?

43:47 What is the role of philosophy in our age of science?

When one thinks of philosophers from Oxford, one thinks of John Locke tucked away in a picturesque garden writing and thinking away. Or, from the last century, such folks as Isaiah Berlin or Sir Bernard Williams. Richard Price offers a new image. A Ph D and Prize Fellow at All Souls College, Richard wrote his thesis on the philosophy of perception and how to draw the line between visible and non-visible properties. Then he went into business, moved to San Francisco, and raised millions of dollars for an online gig. If you'd like to read his thesis you can easily do so by logging on to Academia.edu, a site for sharing research that he founded.

Price says the site accelerates academic research by allowing academics (and non-academic researchers) to share their work, even before it's published in a standard journal. We talk to Richard about the features of the site and what makes it different from some of the other sharing platforms such as Mendeley and Google Scholar. Richard also shares how he became a businessman, saying that "there are connections between entrepreneurship and philosophy." One of my favorite questions of late has been what role philosophers play in our present age of science. With an open style and a pleasant agreeableness, Price is happy to speak up for his fellow philosophers.

A Revolution in Data Gathering: John Wilbanks

Podcast brought to you by: Assay Depot - the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.

Guest:

John Wilbanks, Senior Fellow , The Kauffman Foundation Bio and Contact Info

Listen (7:31) Disconnect between informed consent and digital technology

Listen (9:26) Consent to Research Project

Listen (5:59) Who will be the early volunteers to share their data?

Listen (11:46) Access2Research petition at White House-now what?

Listen (3:59) Can you describe the nature of the legal threats you've received?

Listen (3:33) Would you donate your child's data to research?

Listen (4:23) Data gathering undergoing a revolution

"I like making it easier to share things," says John Wilbanks, a senior fellow at the Kauffman Foundation. Also a member of the Board of Directors for Sage Bionetworks, Wilbanks has been involved in numerous projects having to do with opening up important content and data. Now he runs the Consent to Research Project where he is designing systems that allow people to donate their research to data. Wilbanks discusses the disconnect that is emerging between informed consent and the realities of the digital revolution. In this comprehensive interview he talks about the Access2Research petition he recently spearheaded to extend the NIH's open access policy to the other federal agencies.

Why does John like making it easier to share things? Hear about his past and find out his thoughts on data gathering in the future.

Listen to Wilbanks' TED talk

1st Hand Access to Research: William Gunn, Mendeley

Podcast Sponsor: Addgene - Today’s Podcast is sponsored by Addgene a non-profit organization facilitating biomedical research by operating a library for published and useful plasmids. Join our collaborative community by depositing to the library or by requesting plasmids for your research. To date, over 1,200 laboratories have contributed to our 18,500 plasmid collection. Find out more at www.addgene.org

Guests:

William Gunn, Head of Academic Outreach, Mendeley Bio and Contact Info

Listen (5:18) Mendeley and the system of science

Listen (5:24) What is altmetrics?

Listen (3:45) Not the publisher, but the discovery tool

Listen (7:28) Desktop manager and other advantages over Google Scholar

Listen (4:04) The recent Finch Report

Listen (3:37) What's your vision for the future of publishing?

Listen (2:46) Getting caught in Hurricane Katrina

William Gunn is head of academic outreach for Mendeley, the new tool for sharing research that everyone is talking about. Introducing us to the concept of altmetrics, William presents the Mendeley desktop manager and other features of Mendeley which separate it from Google Scholar. Mr. Gunn discusses his vision for the future of open access publishing and shares a personal story of evacuating New Orleans during Katrina.

A 'Revolution in Science' with Joseph Jackson

Podcast brought to you by: Assay Depot - the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.

Guest:

Joseph Jackson, StartUp Science Bio and Contact Info

Chapters (Move marker to advance)

0:50 StartUp Science Event

2:41 What do you mean by a revolution in science?

6:45 Orthodox economics doesn't account for the impact of technology

25:33 What does privacy mean today?

39:06 "I believe it's attainable to eliminate aging in the next 50 years."

46:53 What is the most influential book you've read?

Joseph Jackson is is a leader in the open science movement. He organizes the yearly Open Science Summit and most recently he's a founding member of StartUp Science, a new event and business plan competition that took place June 15, 16th here in Silicon Valley.

Joseph believes there's an organizational revolution going on in science. Not shy of being a futurist, Joseph says that it's possible to eliminate aging in the next 50 years.

Barry Bunin, CEO, Collaborative Drug Discovery

Podcast brought to you by: Assay Depot - the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.

Guest:

Barry Bunin, PhD, CEO, Collaborative Drug Discovery Bio and Contact Info

Chapters (Move marker to advance)

0:53 Multiple brains work better than one.

7:15 The perfect platform for the NIH?

11:47 Customer examples

15:07 Is there an intrinsic conflict between collaboration and security?

20:21 What's your vision for your site?

23:47 Has the platform evolved?

27:21 Working with Jonathan Ellman

29:16 Choosing chemistry over Eastern religion

32:58 BONUS

Thought leaders of the pharma industry are more and more embracing open collaboration as a major solution to the present industry crisis. Barry Bunin is here to talk about his company, Collaborative Drug Discovery, a platform to help companies share their data. Barry says that the company offers the whole continuum of privacy options and says the site has eight layers of security. Will it be a site like this which enables pharma to share and speeds up solutions for disease? Barry also shares some of his personal story and why he chose chemistry over Eastern religion.

When Drug Discovery Gets Personal: Scott Johnson, Myelin Repair Foundation

Podcast brought to you by: Collaborative Drug Discovery, leading the paradigm shift in collaborative, web-based drug discovery research. Make Drug Discovery fun again!

Guest:

Scott Johnson, President and Founder, Myelin Repair Foundation Bio and Contact Info

Chapters (Move marker to advance)

1:13 Focus of the Foundation

2:24 Personal struggle with MS

3:51 Coming at medical research with fresh eyes

12:09 How are you incentivizing your research partners to share in real time?

22:05 How are you bridging the translational gap?

28:45 "I was reading Newsweek one day and . . ."

34:38 Getting into the Gordon Conference on myelin without a Ph D

37:30 Is this the better model for drug discovery?

39:43 Raising funds for a non-profit

As we noted in a recent blog about patient involvement in the industry, there is a growing trend for patient disease foundations to get directly involved with drug development. Today we’re at the offices of the Myelin Repair Foundation, a patient foundation which has come up with a new model for developing drugs for multiple scelerosis. And a model which could perhaps be used by many others to create cures for disease. Joining us is the founder of the foundation, a man diagnosed with MS himself, Scott Johnson. I typically ask guests where they get their passion, but there's no need to as Scott as he recounts going from being an entrepreneur in the entertainment industry to developing and leading a new model for medical research.

BioConference Live 'Clinical Diagnostics': A Preview

Podcast Sponsor: Ingenuity - iReport, the fastest and most accurate way to get biological meaning from your expression data. www.ingenuity.com/get iReport/

Guests:

Greg Cruikshank, President, BioConferenceLive Bio and Contact Info

Listen (8:28) Greg Cruikshank previews changes and highlights

Whitney Green, VP, Molecular Diagnostics, Roche Bio and Contact Info

Listen (7:16) Whitney Green talks about Roche strategy and participation in the conference

On May 23-24, BioConference Live will be producing their 3rd annual Clinical diagnostics online conference. The event brings together clinicians, researchers, and medical experts from around the world to learn about recent advances in clinical diagnostics and medicine. The show is free and the venue a click away on your computer. Attendees can earn CME and CE Credits at no charge by watching live video presentations. Users can browse the virtual exhibit hall and interact with vendors such as Roche Diagnostics, Siemens, and Cardinal Health. Today we’re joined by some guests to preview the conference. First we’ll talk with the founder of BioConference Live, Greg Cruikshank. Then to the the VP of Roche’s diagnostics division, Whitney Green.

Opening up the World of Drug Discovery: Assay Depot's Kevin Lustig

Podcast brought to you by: Geschickten Biosciences the world’s first biology knowledge discovery services company focused on democratizing NGS data analyses. To manage, analyze and visualize your NGS data please login to interpretomics.co

Guest:

Kevin Lustig, PhD, CEO, Assay Depot Bio and Contact Info

Opening up the World of Drug Discovery: Kevin Lustig, Assay Depot from mendelspod on Vimeo.

Listen (4:33) Assay Depot

Listen (6:33) What took so long to get an Amazon for the life sciences?

Listen (7:18) Empowering individual scientists

Listen (3:33) What is a programmable lab?

Listen (5:55) Drug development from the beach at Waikiki

Listen (2:07) Open Science Challenge

As the pharma industry moves toward more outsourcing and virtual business structures, a new online exchange has emerged as a popular platform for life science transactions. AssayDepot.com has been called by Atul Butte, bioinformatics professor at Stanford, a Home Depot for science. In today's show we talk with the co-founder and CEO of Assay Depot, Kevin Lustig. Originally Kevin and his colleague created the site to complement what was going to be a new CRO in San Diego. Soon they realized the site itself, with features borrowed from Amazon, Kayak, and Google, offered a greater business opportunity than another CRO. Kevin talks about the platform and its various features and at large about new trends in pharma.

Speaking Out: Bernard Munos Part II

Podcast brought to you by: Assay Depot - the world's largest cloud-based Research Exchange for pharmaceutical research services.

Guest:

Bernard Munos, Founder of InnoThink Bio and Contact Info

Listen (5:25) What to do to correct poor situation?

Listen (4:30) Open source R & D

Listen (4:28) Critical mass becomes one human brain

Listen (8:40) Issue of IP and other challenges for open model

Listen (5:07) Examples of open source R & D

Listen (9:53) Is this a personal calling?

Listen (4:31) Is your message taking hold with big pharma?

Listen (5:20) When it comes to drug R & D, the bolder the better

Bernard Munos is the founder of InnoThink, a partnership dedicated to bringing innovation to the pharmaceutical industry. In this second of a two-part interview, Bernard presents his solutions for radically improving the way drug development is done. Bernard, who calls himself an 'apostle of innovation', is a proponent of radical disruption, specifically going to an open source model of R&D, with smaller, even virtual companies. Speaking out after a 30 year career at Lilly, Bernard is not constrained by a corporate boss or short-sighted shareholders. He's calling for big change, "the bolder the better."

hackedChatting with Bernard at a local winery in Los Gatos



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup